Qualitron Bio Medica Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 15 Year, 29 Days
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 5.50 M
- Revenue Growth %
- Profit Growth 81.00%
- Ebitda 84.55%
- Net Worth -10.97%
- Total Assets -40.37%
About Qualitron Bio Medica
Qualitron Bio Medica Private Limited (QBMPL) is a Private Limited Indian Non-Government Company incorporated in India on 25 January 2010 and has a history of 15 years. Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹5.50 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Mohit Jain and Manish Jain serve as directors at the Company.
Company Details
- Location
Thane, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24290MH2010PTC199340
- Company No.
199340
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Jan 2010
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Qualitron Bio Medica?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manish Jain  | Director | 25-Jan-2010 | Current |
| Mohit Jain | Director | 25-Jan-2010 | Current |
Financial Performance of Qualitron Bio Medica.
Qualitron Bio Medica Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 81% increase in profit. The company's net worth observed a substantial decline by a decrease of 10.97%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Qualitron Bio Medica?
In 2020, Qualitron Bio Medica had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Neiss Labs LimitedMohit Jain and Manish Jain are mutual person
Neiss Wellness (India) LimitedMohit Jain and Manish Jain are mutual person
Merito Global LlpMohit Jain and Manish Jain are mutual person
- Sigra Worldwide Private Limited
Mohit Jain and Manish Jain are mutual person
- Onecore Pharma Private Limited
Mohit Jain is a mutual person
- Ignite Discovery Labs Private Limited
Mohit Jain is a mutual person
Charges (Loans)
₹0
₹5.50 M
Charges Breakdown by Lending Institutions
- Others : 0.35 Cr
- Punjab National Bank : 0.20 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Mar 2017 | Others | ₹3.50 M | Satisfied |
| 16 Oct 2010 | Punjab National Bank | ₹2.00 M | Satisfied |
How Many Employees Work at Qualitron Bio Medica?
Unlock and access historical data on people associated with Qualitron Bio Medica, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Qualitron Bio Medica, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Qualitron Bio Medica's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.